GemPharmatech Co., Ltd. (SHA:688046)

Market Cap	7.39B
Revenue (ttm)	721.26M
Net Income (ttm)	104.39M
Shares Out	408.99M
EPS (ttm)	0.25
PE Ratio	71.69
Forward PE	57.03
Dividend	0.14 (0.78%)
Ex-Dividend Date	Jul 11, 2025

Volume	3,211,783
Average Volume	4,220,391
Open	17.50
Previous Close	17.66
Day's Range	17.50 - 18.33
52-Week Range	10.44 - 20.50
Beta	0.60
RSI	48.90
Earnings Date	Oct 23, 2025

About GemPharmatech

GemPharmatech Co., Ltd., a contract research organization, provides genetically engineered mouse models and preclinical research services to the scientific community worldwide. The company offers mouse models, including knockout and conditional knockout mouse, disease mouse, immunodeficient mouse, germ-free mouse, and tool mice models, as well as operates wild mouse project. It also provides custom model generation, preclinical testing, germ-free and microbiome, cell lines and customization, custom breeding, animal quality testing, and other se...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2017
• Employees: 1,578
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 688046

Financial Performance

In 2024, GemPharmatech's revenue was 686.84 million, an increase of 10.39% compared to the previous year's 622.19 million. Earnings were 109.82 million, a decrease of -30.89%.